Matthew Webb
Physician Assistant · Barbourville, KYNPI 1023355237
Payments from drug & device makers
Across 116 payments — averaging $14.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$528
- Lilly USA, LLC$220
- Amgen$135
- AstraZeneca$133
- Novo Nordisk$104
- Pfizer$83
- plus $436 from 14 others
What the payments were for
- Food & beverage$1,639100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $528 |
| Lilly USA, LLC | 15 | $220 |
| Amgen | 6 | $135 |
| AstraZeneca(2 entities) | 8 | $133 |
| Novo Nordisk | 7 | $104 |
| Pfizer | 5 | $83 |
| Merck | 4 | $65 |
| Biohaven Pharmaceuticals, Inc. | 4 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $57 |
| Exact Sciences | 2 | $35 |
| Amarin Pharma, Inc. | 2 | $31 |
| Abiomed | 1 | $31 |
| Astellas Pharma US Inc | 2 | $29 |
| GSK | 2 | $27 |
| Boehringer Ingelheim | 2 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Novartis | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| Phadia US Inc. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
How this compares
$1,639 in reported general payments places this provider in the 75th percentile of 1,448 physician assistant providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 89 | $97,367 |
| JardianceEmpagliflozin | 45 | $47,586 |
| TrulicityDulaglutide | 40 | $39,840 |
| Repatha SureclickEvolocumab | 31 | $16,851 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $10,239 |
| FarxigaDapagliflozin Propanediol | 13 | $7,529 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 12 | $7,212 |
| Aripiprazole | 12 | $1,810 |
| Ventolin HfaAlbuterol Sulfate | 28 | $1,695 |
| Gabapentin | 139 | $1,308 |
| Rosuvastatin Calcium | 66 | $716 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $665 |
| Montelukast Sodium | 47 | $639 |
| Omeprazole | 52 | $622 |
| Levothyroxine Sodium | 90 | $608 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $220 | $137,207129 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $26 | $54,79857 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $133 | $17,76730 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,448 physician assistant providers in Kentucky.
Other physician assistant in Barbourville
- Brandice HarrisonLexington$745K
- Lauren MeadeLexington$656K
- Melissa DavisLouisville$362K
- Kara MuddLouisville$98K
- Seth KingBowling Green$91K
- Marty MullinsHazard$63K
- Lauri GarnerVersailles$33K
- Robert TatumLouisville$29K
- Michelle JonesLexington$29K
- Grace IsaacsLouisville$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.